Ireland· IE-PA-PPA23080/034/001
ZANIDIP 10 mg Film-coated Tablets
A qc08ca13 product containing lercanidipine hydrochloride, registered in Ireland by Merit Pharmaceuticals Limited.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Lercanidipine hydrochloride
- Manufacturer
- Merit Pharmaceuticals Limited
- Country
- Ireland (IE)
- ATC code
- QC08CA13
- ATC class
- QC08CA13
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA23080/034/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lercanidipine hydrochloride in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJOSPITENEgis Pharmaceuticals PLC, Budapešť
- PolandJospitenEgis Pharmaceuticals PLC
- SpainLERCADIP 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULACasen Recordati S.L.
- ItalyAYRDOZELIADAY ZERO EHF
- FranceLERCAN 10 mg, comprimé pelliculé sécableBOUCHARA-RECORDATI
- BelgiumEnalapril/Lercanidipin Sandoz 10 mg - 10 mgSandoz
- SwitzerlandLercanidipin axapharm
- FinlandLercamedOmet Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Lercanidipin Accord, Lercanidipin Actavis
- Belgium · Lercanidipin Sandoz, Lercanidipine Ab
- Bulgaria · Areta, Арета
- Cyprus · Zanedip
- Czechia · Jospiten, Kapidin
- Germany · Carmen, Corifeo
- Denmark · Lercanidipine, Lercanidipine Accord
- Estonia · Lercanidipine Accord, Lercanidipine Actavis
- Spain · Lercadip, Lercanidipino Aurovitas Spain
- Finland · Lercamed, Lercanidipin Hydrochlorid Actavis
- France · Lercan, Lercanidipine Accord
- United Kingdom (Northern Ireland) · Lercanidipine Generics [uk], Lercanidipine Hcl Recordati Industria Chimica E Farmaceutica S.P.A.
- Greece · Lercadip, Zanidip
- Croatia · Lercanil, Pinox
- Hungary · Kapidin, Lecalpin
- Iceland · Lercanidipin Actavis, Lerkanidipin Actavis
- Italy · Cardiovasc, Lercadip
- Lithuania · Lercanidipine Actavis, Lercanidipine Ingen Pharma
- Luxembourg · Lercanidipine Eg, Zanidip
- Latvia · Kapidin, Lercanidipine Accord
- Malta · Lercanidipine Torrent
- Netherlands · Lercanidipine Accord, Lercanidipine Hcl Amarox
- Norway · Lercanidipine Accord, Lercanidipine Orion
- Poland · Jospiten, Kapizen
- Portugal · Lercanidipina Alter, Lercanidipina Atral
- Romania · Lercanidipină Gemax Pharma, Leridip
- Sweden · Lercamed, Lercanidipine Accord
- Slovenia · Lecalpin, Lercapress
- Slovakia · Kapidin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4f72f2b-f010-44ed-be9e-cf169b38dc6d GET /v1/drugs/f4f72f2b-f010-44ed-be9e-cf169b38dc6d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"QC08CA13"
],
"strength": null,
"pa_number": "PPA23080/034/001",
"substances": [
"Lercanidipine hydrochloride"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "04/04/2025",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0020-002-003"
}See everything about lercanidipine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.